Paper
7 August 2019 Methylene blue as a photosensitizer in the photodynamic therapy of breast cancer cell lines
Author Affiliations +
Proceedings Volume 11070, 17th International Photodynamic Association World Congress; 11070A0 (2019) https://doi.org/10.1117/12.2525454
Event: 17th International Photodynamic Association World Congress, 2019, Cambridge, Massachusetts, United States
Abstract
We compared MB-PDT effect on two breast cancer cell lines: MDA-MB-231 from a triple negative adenocarcinoma, and T47D from a ductal cell tumor of woman. Methylene blue concentrations at 5, 10 and 20 μM and red light doses of 20, 40 and 60 J/cm2 were employed. Cell viability was evaluated with the MTT test, obtaining around 80% of inhibition with 20 μM and 60 J/cm2 of light dose.
© (2019) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
JC Atenco-Cuautle, T. Spezzia-Mazzocco, R. Ramos-Garcia, JC Ramirez-San-Juan, J. Ramirez-Ramirez, and MG Delgado-Lopez "Methylene blue as a photosensitizer in the photodynamic therapy of breast cancer cell lines", Proc. SPIE 11070, 17th International Photodynamic Association World Congress, 11070A0 (7 August 2019); https://doi.org/10.1117/12.2525454
Advertisement
Advertisement
RIGHTS & PERMISSIONS
Get copyright permission  Get copyright permission on Copyright Marketplace
KEYWORDS
Breast cancer

Photodynamic therapy

Picosecond phenomena

Toxicity

Absorbance

Biomedical optics

Tumors

Back to Top